An anonymous director reports

PHARMACORP ANNOUNCES INVESTOR RELATIONS AGREEMENT

Pharmacorp Rx Inc. has entered into a public listing service agreement with LodeRock Advisors Inc. to provide the corporation with investor relations services, with a primary focus on developing and executing a 12-month investor relations strategy, advising senior management on investor-related matters, and maintaining strong relationships with analysts, investors and the broader investment community. LodeRock will also serve as the primary investor contact, manage investor messaging and presentation materials, co-ordinate external reporting with finance teams, and provide timely market intelligence and feedback.

Pursuant to the agreement, LodeRock has agreed to provide investor relations and communications services to the corporation in exchange for a monthly fee of $10,000 for the first six months and $12,500 thereafter. The fees are payable monthly and are subject to increase by 2.5 per cent on the first anniversary of the agreement. The agreement will terminate upon the fulfilment of the services or by either party upon 90 days written notice. LodeRock has an arm's-length relationship with the corporation, and has no interest, directly or indirectly, in the corporation or its securities, or any right or intent to acquire such an interest. The agreement remains subject to acceptance by the TSX Venture Exchange.

About Pharmacorp Rx Inc.

Pharmacorp is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. Through a combination of capital, strategic support and operational expertise, Pharmacorp is building a national network of community pharmacies under the Pharmachoice Canada banner. Pharmacorp currently operates seven Pharmachoice Canada bannered pharmacies, and will continue to acquire both Pharmachoice Canada bannered and independent pharmacies across Canada, rebranding non-bannered locations under the Pharmachoice Canada platform in accordance with its strategic alliance with Pharmachoice Canada. Pharmacorp shares trade on the TSX Venture Exchange under the symbol PCRX.

We seek Safe Harbor.